| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |
| 02/22/2006 | CN1738636A Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases wit |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1738601A Dermastick thickened ointment |
| 02/22/2006 | CN1738599A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/22/2006 | CN1738591A Method of stimulating hair growth using benzopyrans |
| 02/22/2006 | CN1736474A Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof |
| 02/22/2006 | CN1736470A Medicinal prescription of skin sterilizing formulation |
| 02/22/2006 | CN1736462A Chinese proprietary medicine making fleece-flower root as main raw material |
| 02/22/2006 | CN1736455A Chinese medicinal composition for treating tinea |
| 02/22/2006 | CN1736448A Medicinal preparation for treating cold abscess and all kinds of body surface ulcer |
| 02/22/2006 | CN1736439A Traditional Chinese medicinal powder for treating psoriasis |
| 02/22/2006 | CN1736437A Medicinal composition for treating dermatosis |
| 02/22/2006 | CN1736428A Method for extracting herbal composite medicine for treating chloasma |
| 02/22/2006 | CN1736427A Ointment for treating traumatic injury and its preparation method |
| 02/22/2006 | CN1736423A Method for preparing externally applied medicine for feet tinea |
| 02/22/2006 | CN1736412A Orally administered composition containing fat soluble ingredient of red sage root |
| 02/22/2006 | CN1736397A Naevus removing ointment |
| 02/22/2006 | CN1736386A Pharmaceutical formulation for treating skin allergy and preparation process thereof |
| 02/22/2006 | CN1736198A Deep penetrating anti-microbial compositions |
| 02/22/2006 | CN1243018C Blood vessel generating inhibitor |
| 02/22/2006 | CN1243000C Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
| 02/22/2006 | CN1242812C Gelling agent of stimulating factor of macrophage colony of recombined human granular leudocytes and preparation method |
| 02/22/2006 | CN1242809C Applications of T-BAM (CD40L) technology in preparation of medicine to treat diseases involving smooth muscle cell |
| 02/22/2006 | CN1242806C Chinese medicinal preparation for treating alphos and ichthyosys |
| 02/22/2006 | CN1242799C Medicine for treating pointed condyloma with pure Chinese medicine |
| 02/22/2006 | CN1242797C Compound barbiers liquid |
| 02/22/2006 | CN1242787C Beverage capable of turning white hair into black hair |
| 02/22/2006 | CN1242781C Medicine for treating urticaria |
| 02/22/2006 | CN1242773C Medicine for treating skin wound and its processing method |
| 02/22/2006 | CN1242760C Powder preparation for treating burn and skin trauma |
| 02/22/2006 | CN1242753C Cauma therapeutic liquid |
| 02/22/2006 | CN1242752C Ointment for curing brandy nose |
| 02/22/2006 | CN1242738C Hair maintaining liquid and special purpose comb thereof |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001914 Compounds |
| 02/21/2006 | US7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 02/21/2006 | US7001606 Biocidal polymers based on guanidine salts |
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/21/2006 | CA2308006C Topical compositions for regulating the oily/shiny appearance of skin |
| 02/21/2006 | CA2267309C Use of 1-hydroxy-2-pyridones for the treatment of skin infections |
| 02/21/2006 | CA2180276C Process for isomerizing linear olefins to isoolefins |
| 02/16/2006 | WO2006016582A1 Liquid culture method for inonotus obliquns |
| 02/16/2006 | WO2006015870A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 02/16/2006 | WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060035979 Inhibitors of transcription factor NF-kappaB |
| 02/16/2006 | US20060035977 Uses of acylated aminopropanediols and sulphur and nitrogen analogues of same f |
| 02/16/2006 | US20060035969 Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 02/16/2006 | US20060035957 Preventive or remedy for bedsore |
| 02/16/2006 | US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/16/2006 | US20060035924 Daily melatonin dosing units |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035819 Novel molecule |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060034945 Composition for restoring damaged skin |
| 02/16/2006 | US20060034892 Composition for topical administration |
| 02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 02/16/2006 | US20060034824 Pharmaceutical composition comprising carriers for products |
| 02/16/2006 | US20060034816 comprises oxidoreductase enzyme in hydrated condition that catalyses conversion of atmospheric oxygen to hydrogen peroxide for transmittal through the dressing to the skin |
| 02/16/2006 | US20060034781 Peroral preparation for prevention or treatment of atopic dermatatis |
| 02/16/2006 | CA2584970A1 Method for the treatment of mammalian skin tissues via pulse irradiation in the presence of a photoactive compound |
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/15/2006 | EP1625844A1 The composition for external use by percutaneous administration |
| 02/15/2006 | EP1624886A2 Methods for increasing cell and tissue viability |
| 02/15/2006 | EP1624852A1 Sun tanning products and products for treatment of the skin before and after exposure to the sun |
| 02/15/2006 | EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 02/15/2006 | EP1154767B1 Substituted stilbene compounds with vascular damaging activity |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735402A Polymer composition including large ring alkatriene compound |
| 02/15/2006 | CN1733295A Externally used solution for recombined human alkaline fibroblast growth factor and process for preparing the same |
| 02/15/2006 | CN1733294A Recombined human alkaline fibroblast growth factor gelling agent and process for preparing the same |
| 02/15/2006 | CN1733270A Medicine composite and process for preparing the same |
| 02/15/2006 | CN1733268A Heat clearing and detoxicating pill containing vomiting nut |
| 02/15/2006 | CN1733265A Chinese traditional medicine injection for traumatology and dermatological department and process for preparing the same |
| 02/15/2006 | CN1733259A Composition for curing psoriasis |
| 02/15/2006 | CN1733252A Powder for curing muscle ulceration and process for preparing the same |
| 02/15/2006 | CN1733209A Injection for restoring pulse beat and process for preparing the same |
| 02/15/2006 | CN1733195A Composition for flecks removal and facial beautification |
| 02/15/2006 | CN1733185A Capsule dragon's blood and process for preparing the same |
| 02/15/2006 | CN1733165A Chinese traditional medicine composition for curing psoriasis, its preparation process and application |
| 02/15/2006 | CN1733163A Plaster for curing carbuncle sore tumour |
| 02/15/2006 | CN1733156A Trauma protecting paster containing aloe, its preparation process and application |
| 02/15/2006 | CN1733141A New preparation for curing chloasma and acne |
| 02/15/2006 | CN1733124A Chinese traditional medicine composition for curing psoriasis, its preparation process and application |
| 02/15/2006 | CN1733123A Medicine for treating skin sore and furuncle |
| 02/15/2006 | CN1733086A Medicine for treating scald and its preparing process |
| 02/15/2006 | CN1733075A Tinea treating drug |
| 02/15/2006 | CN1733074A Externally applied medicine for treating dermatosis |
| 02/15/2006 | CN1733065A Externally applied scouring liquor for alphos |
| 02/15/2006 | CN1733063A Orally medicine for treating vitiligo and production method thereof |
| 02/15/2006 | CN1733058A Use of legume products for the treatment and prevention of radiotherapy-induced skin damage |
| 02/15/2006 | CN1733057A Chinese medicine preparation for treating tinea and its preparation process |
| 02/15/2006 | CN1733051A Medicine for treating pig leucorrhea and scabies |
| 02/15/2006 | CN1733040A Laggera pterodonta buccal tablet, its preparation process and quality control method |
| 02/15/2006 | CN1733010A Externally applied powder for astringing sore, removing necrotic tissue and regenerating tissue |